Fong Clow
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
- Vitamin D Research Studies
Papers in
- Genetics 26
- Chronic Lymphocytic Leukemia Research 26
-
- Lymphoma Diagnosis and Treatment 18
- Co-authors
- Danelle F. James (17 shared papers)Ian W. Flinn (6 shared papers)Lori Styles (7 shared papers)Cathy Zhou (3 shared papers)Susan O’Brien (10 shared papers)Carol Moreno (2 shared papers)Fatih Demırkan (2 shared papers)Alessandra Tedeschi (2 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (6 papers)British Journal of Haematology (3 papers)Biology of Blood and Marrow Transplantation (2 papers)Annals of Hematology (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Fong Clow
30 papers receiving 1.2k citations
Fong Clow's Hit Papers
Peers
Comparison fields: 5 of 68
- Genetics 814
- Pathology and Forensic Medicine 801
- Hematology 340
- Immunology 292
- Gastroenterology 58
Countries citing papers authored by Fong Clow
This map shows the geographic impact of Fong Clow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fong Clow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fong Clow more than expected).
Fields of papers citing papers by Fong Clow
This network shows the impact of papers produced by Fong Clow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fong Clow. The network helps show where Fong Clow may publish in the future.
Co-authors
The 25 scholars most cited alongside Fong Clow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2018 | 380 |
| 2 | 2007 | 235 | |
| 3 | 2015 | 91 | |
| 4 | 2017 | 90 | |
| 5 | 2019 | 66 | |
| 6 | 2016 | 51 | |
| 7 | 2012 | 44 | |
| 8 | 2013 | 40 | |
| 9 | 2018 | 32 | |
| 10 | 2018 | 30 | |
| 11 | 2015 | 30 | |
| 12 | 2015 | 20 | |
| 13 | 2012 | 19 | |
| 14 | 2024 | 16 | |
| 15 | 2014 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2006 | 8 | |
| 18 | 2014 | 8 | |
| 19 | 2013 | 8 | |
| 20 | 2014 | 7 |
About Fong Clow
Fong Clow is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Gastroenterology and Immunology, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (26 papers), Lymphoma Diagnosis and Treatment (18 papers), Chronic Myeloid Leukemia Treatments (10 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Genetics (814 citations), Pathology and Forensic Medicine (801 citations), Hematology (340 citations), Immunology (292 citations) and Gastroenterology (58 citations). Fong Clow has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Danelle F. James, Ian W. Flinn, Lori Styles, Cathy Zhou, Susan O’Brien, Carol Moreno, Fatih Demırkan, Alessandra Tedeschi, Martin Šimkovič and Jan Novák. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Biology of Blood and Marrow Transplantation and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.